Laylor Ruthline, Dewchand Hamlata, Simpson Elizabeth, Dazzi Francesco
Department of Immunology and Transplantation Biology Section, Imperial College Faculty of Medicine, Hammersmith Hospital, London W12 0NN, UK.
Transplantation. 2005 Jun 15;79(11):1484-91. doi: 10.1097/01.tp.0000159027.81569.4a.
The establishment of host-versus-graft (HvG) tolerance is the primary aim of reduced intensity conditioning (RIC) regimens for allogeneic stem cell transplantation (SCT). It remains to be clarified to what extent recipient myeloablation is fundamental in the establishment of donor chimerism.
We have addressed this question in a murine model of RIC SCT in which the donor-recipient combination produces HvG against the male specific minor histocompatibility antigen HY. In this system engraftment can be monitored by RT-PCR and HvG effectors enumerated by tetramer analysis.
We demonstrate that the dose of irradiation influences donor hemopoietic engraftment and affects generation of anti-donor specific T cells. Chimeric recipients do not mount a HvG immune response, becoming selectively tolerant, as demonstrated by the long term acceptance of skin grafts of donor but not third party origin. However, HvG tolerance is not sufficient to secure engraftment since, even in the absence of HvG, partial myeloablation was still required. The "space" produced by myeloablation and the consequent potential for donor cell expansion could also affect HvG tolerance, since its induction is severely impaired when donor hematopoietic cells have reduced proliferative capacity.
We conclude that both some degree of myeloablation and HvG tolerance are required for successful engraftment, and that the capacity of donor cells to proliferate influences the induction of HvG tolerance.
建立宿主对移植物(HvG)耐受性是异基因干细胞移植(SCT)中减低预处理强度(RIC)方案的主要目标。受体骨髓消融在供体嵌合体建立过程中的重要程度仍有待阐明。
我们在RIC SCT的小鼠模型中解决了这个问题,在该模型中供体 - 受体组合产生针对雄性特异性次要组织相容性抗原HY的HvG。在这个系统中,可以通过逆转录聚合酶链反应(RT-PCR)监测植入情况,并通过四聚体分析计数HvG效应细胞。
我们证明照射剂量会影响供体造血植入,并影响抗供体特异性T细胞的产生。嵌合受体不会产生HvG免疫反应,而是变得选择性耐受,这通过长期接受供体而非第三方来源的皮肤移植得以证明。然而,HvG耐受性不足以确保植入,因为即使在没有HvG的情况下,仍需要部分骨髓消融。骨髓消融产生的“空间”以及随之而来的供体细胞扩增潜力也可能影响HvG耐受性,因为当供体造血细胞增殖能力降低时,其诱导会严重受损。
我们得出结论,成功植入需要一定程度的骨髓消融和HvG耐受性,并且供体细胞的增殖能力会影响HvG耐受性的诱导。